Canntab Therapeutics Ltd
CNSX:PILL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Canntab Therapeutics Ltd
Change in Working Capital
Canntab Therapeutics Ltd
Change in Working Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Canntab Therapeutics Ltd
CNSX:PILL
|
Change in Working Capital
-CA$182.5k
|
CAGR 3-Years
17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
High Tide Inc
XTSX:HITI
|
Change in Working Capital
CA$4.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Canopy Growth Corp
TSX:WEED
|
Change in Working Capital
CA$12.9m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
-1%
|
|
|
OrganiGram Holdings Inc
TSX:OGI
|
Change in Working Capital
-CA$20.5m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-28%
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Change in Working Capital
CA$8.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Change in Working Capital
-$34.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Canntab Therapeutics Ltd
Glance View
Canntab Therapeutics Ltd. is a biopharmaceutical company. The company is headquartered in Toronto, Ontario. The company went IPO on 2011-04-21. The firm is focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The firm operates in one reportable operating, being engaged in the medical marijuana business. All property and equipment, right-of-use assets and intangible assets are located in Canada. Its hard pill cannabinoid formulations provide doctors, patients and consumers with medical grade solutions. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet. The company holds cannabis standard processing and sales for medical purposes license, a cannabis research license, and an industrial hemp license from health Canada.
See Also
What is Canntab Therapeutics Ltd's Change in Working Capital?
Change in Working Capital
-182.5k
CAD
Based on the financial report for May 31, 2022, Canntab Therapeutics Ltd's Change in Working Capital amounts to -182.5k CAD.
What is Canntab Therapeutics Ltd's Change in Working Capital growth rate?
Change in Working Capital CAGR 3Y
17%
Over the last year, the Change in Working Capital growth was 72%. The average annual Change in Working Capital growth rates for Canntab Therapeutics Ltd have been 17% over the past three years .
